{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:31:17Z","timestamp":1773322277743,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,3,25]],"date-time":"2008-03-25T00:00:00Z","timestamp":1206403200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Malignant gliomas are lethal cancers, highly dependent on angiogenesis and treatment options and prognosis still remain poor for patients with recurrent glioblastoma multiforme (GBM). Ephs and ephrins have many well-defined functions during embryonic development of central nervous system such as axon mapping, neural crest cell migration, hindbrain segmentation and synapse formation as well as physiological and abnormal angiogenesis. Accumulating evidence indicates that Eph and ephrins are frequently overexpressed in different tumor types including GBM. However, their role in tumorigenesis remains controversial, as both tumor growth promoter and suppressor potential have been ascribed to Eph and ephrins while the function of EphA7 in GBM pathogenesis remains largely unknown.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this study, we investigated the immunohistochemical expression of EphA7 in a series of 32 primary and recurrent GBM and correlated it with clinical pathological parameters and patient outcome. In addition, intratumor microvascular density (MVD) was quantified by immunostaining for endothelial cell marker von Willebrand factor (vWF).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Overexpression of EphA7 protein was predictive of the adverse outcome in GBM patients, independent of MVD expression (p = 0.02). Moreover, high density of MVD as well as higher EphA7 expression predicted the disease outcome more accurately than EphA7 variable alone (p = 0.01). There was no correlation between MVD and overall survival or recurrence-free survival (p &gt; 0.05). However, a statistically significant correlation between lower MVD and tumor recurrence was observed (p = 0.003).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The immunohistochemical assessment of tissue EphA7 provides important prognostic information in GBM and would justify its use as surrogate marker to screen patients for tyrosine kinase inhibitor therapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-8-79","type":"journal-article","created":{"date-parts":[[2008,3,25]],"date-time":"2008-03-25T19:13:17Z","timestamp":1206472397000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Increased expression of EphA7 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients"],"prefix":"10.1186","volume":"8","author":[{"given":"Lin-Fang","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil","family":"Fokas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janko","family":"Juricko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Pagenstecher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Engenhart-Cabillic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Xiang","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,25]]},"reference":[{"key":"1017_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/jnen\/64.6.479","volume":"64","author":"H Ohgaki","year":"2005","unstructured":"Ohgaki H, Kleihues P: Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol. 2005, 64: 479-489.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1017_CR2","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s00109-004-0564-x","volume":"82","author":"G Reifenberger","year":"2004","unstructured":"Reifenberger G, Collins VP: Pathology and molecular genetics of astrocytic gliomas. J Mol Med. 2004, 82: 656-670. 10.1007\/s00109-004-0564-x.","journal-title":"J Mol Med"},{"key":"1017_CR3","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrc866","volume":"2","author":"Y Zhu","year":"2002","unstructured":"Zhu Y, Parada LF: The molecular and genetic basis of neurological tumours. Nat Rev Cancer. 2002, 2: 616-626. 10.1038\/nrc866.","journal-title":"Nat Rev Cancer"},{"key":"1017_CR4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0896-6273(92)90177-F","volume":"9","author":"J Schlessinger","year":"1992","unstructured":"Schlessinger J, Ullrich A: Growth factor signaling by receptor tyrosine kinases. Neuron. 1992, 9: 383-391. 10.1016\/0896-6273(92)90177-F.","journal-title":"Neuron"},{"key":"1017_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1146\/annurev.cb.10.110194.001343","volume":"10","author":"P van der Geer","year":"1994","unstructured":"van der Geer P, Hunter T, Lindberg RA: Receptor protein-kinases and their signal transduction pathways. Annu Rev Cell Biol. 1994, 10: 251-337. 10.1146\/annurev.cb.10.110194.001343.","journal-title":"Annu Rev Cell Biol"},{"key":"1017_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev.neuro.21.1.309","volume":"21","author":"JG Flanagan","year":"1998","unstructured":"Flanagan JG, Vanderhaeghen P: The ephrins and Eph receptors in neural development. Annu Rev Neurosci. 1998, 21: 309-345. 10.1146\/annurev.neuro.21.1.309.","journal-title":"Annu Rev Neurosci"},{"key":"1017_CR7","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1242\/dev.126.10.2033","volume":"126","author":"N Holder","year":"1999","unstructured":"Holder N, Klein R: Eph receptors and ephrins: effectors of morphogenesis. Development. 1999, 126: 2033-2044.","journal-title":"Development"},{"key":"1017_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrm856","volume":"3","author":"K Kullander","year":"2002","unstructured":"Kullander K, Klein R: Mechanisms and functions of Eph and ephrin signaling. Nat Rev Mol Cell Biol. 2002, 3: 475-486. 10.1038\/nrm856.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1017_CR9","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/nrm1662","volume":"6","author":"EB Pasquale","year":"2005","unstructured":"Pasquale EB: Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol. 2005, 6: 462-475. 10.1038\/nrm1662.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1017_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/0092-8674(95)90421-2","volume":"82","author":"M Tessier-Lavigne","year":"1995","unstructured":"Tessier-Lavigne M: Eph receptor tyrosine kinases, axon repulsion, and the development of topographic maps. Cell. 1995, 82: 345-348. 10.1016\/0092-8674(95)90421-2.","journal-title":"Cell"},{"key":"1017_CR11","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/0896-6273(95)90335-6","volume":"14","author":"JW Winslow","year":"1995","unstructured":"Winslow JW, Moran P, Valverde J, Shih A, Yuan JQ, Wong SC, Tsai SP, Goddard A, Henzel WJ, Hefti F, Beck KD, Caras IW: Cloning of AL-1, a ligand for an Eph-related tyrosine kinase receptor involved in axon bundle formation. Neuron. 1995, 14: 973-981. 10.1016\/0896-6273(95)90335-6.","journal-title":"Neuron"},{"key":"1017_CR12","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0896-6273(00)81240-4","volume":"18","author":"HU Wang","year":"1997","unstructured":"Wang HU, Anderson DJ: Eph family transmembrane ligands can mediate repulsive guidance of trunk neural migration and motor axon outgrowth. Neuron. 1997, 18: 383-396. 10.1016\/S0896-6273(00)81240-4.","journal-title":"Neuron"},{"key":"1017_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.brainresrev.2005.02.001","volume":"49","author":"A Martinez","year":"2005","unstructured":"Martinez A, Soriano E: Functions of ephrin\/Eph interactions in the development of the nervous system: emphasis on the hippocampal system. Brain Res Brain Res Rev. 2005, 49: 211-226. 10.1016\/j.brainresrev.2005.02.001.","journal-title":"Brain Res Brain Res Rev"},{"key":"1017_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1006\/mcne.1997.0630","volume":"9","author":"G Lemke","year":"1997","unstructured":"Lemke G: A coherent nomenclature for Eph receptors and their ligands. Mol Cell Neurosci. 1997, 9: 331-332. 10.1006\/mcne.1997.0630.","journal-title":"Mol Cell Neurosci"},{"key":"1017_CR15","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/383722a0","volume":"383","author":"SJ Holland","year":"1996","unstructured":"Holland SJ, Gale NW, Mbamalu G, Yancopoulos GD, Henkemeyer M, Pawson T: Bidirectional signaling through the EPH-family receptor Nuk and its transmembrane ligands. Nature. 1996, 383: 722-725. 10.1038\/383722a0.","journal-title":"Nature"},{"key":"1017_CR16","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.7973638","volume":"266","author":"S Davis","year":"1994","unstructured":"Davis S, Gale NW, Aldrich TH, Maisonpierre PC, Lhotak V, Pawson T, Goldfarb M, Yancopoulos GD: Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science. 1994, 266: 816-819. 10.1126\/science.7973638.","journal-title":"Science"},{"key":"1017_CR17","doi-asserted-by":"crossref","first-page":"7789","DOI":"10.1523\/JNEUROSCI.23-21-07789.2003","volume":"23","author":"LQ Bundesen","year":"2003","unstructured":"Bundesen LQ, Scheel TA, Bregman BS, Kromer LF: Ephrin-B2 and EphB2 regulation of astrocyte-meningeal fibroblast interactions in response to spinal cord lesions in adult rats. J Neurosci. 2003, 23: 7789-7800.","journal-title":"J Neurosci"},{"key":"1017_CR18","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0002-9440(10)62998-7","volume":"167","author":"M Nakada","year":"2005","unstructured":"Nakada M, Niska JA, Tran NL, McDonough WS, Berens ME: EphB2\/R-Ras signaling regulates glioma cell adhesion, growth, and invasion. Am J Pathol. 2005, 167: 565-576.","journal-title":"Am J Pathol"},{"key":"1017_CR19","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1158\/0008-5472.CAN-03-3667","volume":"64","author":"M Nakada","year":"2004","unstructured":"Nakada M, Niska JA, Miyamori H, McDonough WS, Wu J, Sato H, Berens ME: The Phosphorylation of EphB2 Receptor Regulates Migration and Invasion of Human Glioma Cells. Cancer Res. 2004, 64: 3179-3185. 10.1158\/0008-5472.CAN-03-3667.","journal-title":"Cancer Res"},{"key":"1017_CR20","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/sj.emboj.7600949","volume":"25","author":"R Erber","year":"2006","unstructured":"Erber R, Eichelsbacher U, Powajbo V, Korn T, Djonov V, Lin J, Hammes HP, Grobholz R, Ullrich A, Vajkoczy P: EphB4 controls blood vascular morphogenesis during postnatal angiogenesis. EMBO J. 2006, 25: 628-641. 10.1038\/sj.emboj.7600949.","journal-title":"EMBO J"},{"key":"1017_CR21","doi-asserted-by":"publisher","first-page":"8492","DOI":"10.1158\/0008-5472.CAN-05-4211","volume":"66","author":"M Nakada","year":"2006","unstructured":"Nakada M, Drake KL, Nakada S, Niska JA, Berens ME: Ephrin-B3 Ligand Promotes Glioma Invasion through Activation of Rac1. Cancer Res. 2006, 66: 8492-8500. 10.1158\/0008-5472.CAN-05-4211.","journal-title":"Cancer Res"},{"key":"1017_CR22","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1593\/neo.05277","volume":"7","author":"M Hatano","year":"2005","unstructured":"Hatano M, Eguchi J, Tatsumi T, Kuwashima N, Dusak JE, Kinch MS, Pollack IF, Hamilton RL, Storkus WJ, Okada H: EphA2 as a glioma-associated antigen: a novel target for glioma vaccines. Neoplasia. 2005, 7: 717-722. 10.1593\/neo.05277.","journal-title":"Neoplasia"},{"key":"1017_CR23","doi-asserted-by":"publisher","first-page":"10815","DOI":"10.1158\/0008-5472.CAN-06-1408","volume":"66","author":"FH Liu","year":"2006","unstructured":"Liu FH, Park PJ, Lai W, Maher E, Chakravarti A, Durso L, Jiang X, Yu Y, Brosius A, Thomas M, Chin L, Brennan C, DePinho RA, Kohane I, Carroll RS, Black PM, Johnson MD: A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastoma. Cancer Res. 2006, 66: 10815-10823. 10.1158\/0008-5472.CAN-06-1408.","journal-title":"Cancer Res"},{"key":"1017_CR24","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1006\/dbio.1996.0173","volume":"177","author":"R Taneja","year":"1996","unstructured":"Taneja R, Thisse B, Rijli FM, Thisse C, Bouillet P, Chambon P: The expression patter of the mouse receptor tyrosine kinase gene MDK1 is conserved through evolution and requires Hoxa-2 for rhombomere-specific expression in mouse embryos. Dev Biol. 1996, 177: 397-412. 10.1006\/dbio.1996.0173.","journal-title":"Dev Biol"},{"key":"1017_CR25","first-page":"97","volume":"10","author":"T Ciossek","year":"1995","unstructured":"Ciossek T, Millauer B, Ulrich A: Identification of alternatively spliced mRNAs encoding variants of MDKs, a novel receptor tyrosine kinase expressed in the murine nervous system. Oncogene. 1995, 10: 97-108.","journal-title":"Oncogene"},{"key":"1017_CR26","first-page":"1573","volume":"10","author":"DM Valenzuela","year":"1995","unstructured":"Valenzuela DM, Rojas E, Griffiths JA, Compton DL, Gisser M, Ip NY, Goldfarb M, Yancopoulos GD: Identification of full length and truncated forms and Ehk-3, a novel member of the Eph receptor tyrosine kinase family. Oncogene. 1995, 10: 1573-1580.","journal-title":"Oncogene"},{"key":"1017_CR27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0169-328X(99)00285-5","volume":"74","author":"T Ciossek","year":"1999","unstructured":"Ciossek T, Ullrich A, West E, Rogers JH: Segregation of the receptor EphA7 form its tyrosine kinase-negative isoform on neurons in adult mouse brain. Molecular Brain Res. 1999, 74: 231-236. 10.1016\/S0169-328X(99)00285-5.","journal-title":"Molecular Brain Res"},{"issue":"1\u20132","key":"1017_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0169-328X(99)00284-3","volume":"74","author":"JH Rogers","year":"1999","unstructured":"Rogers JH, Ciossek T, Ullrich A, West E, Hoare M, Muir EM: Distribution of the receptor EphA7 and its ligands in development of the mouse nervous system. Molecular Brain Res. 1999, 74 (1\u20132): 225-230. 10.1016\/S0169-328X(99)00284-3.","journal-title":"Molecular Brain Res"},{"key":"1017_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/35041577","volume":"408","author":"J Holmberg","year":"2000","unstructured":"Holmberg J, Clarke DL, Fris\u00e9n J: Regulation of repulsion versus adhesion by different splice forms of an Eph receptor. Nature. 2000, 408: 203-206. 10.1038\/35041577.","journal-title":"Nature"},{"issue":"7","key":"1017_CR30","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/jnr.21048","volume":"84","author":"JD Figueroa","year":"2006","unstructured":"Figueroa JD, Benton RL, Velazquez I, Torrado AI, Ortiz CM, Hernandez CM, Diaz JJ, Magnuson DS, Whittemore SR, Miranda JD: Inhibition of EphA7 up-regulation after spinal cord injury reduces apoptosis and promotes locomotor recovery. J Neuroscience Res. 2006, 84 (7): 1438-1451. 10.1002\/jnr.21048.","journal-title":"J Neuroscience Res"},{"key":"1017_CR31","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/nature03651","volume":"435","author":"V Depaepe","year":"2005","unstructured":"Depaepe V, Suarez-Gonzalez N, Dufour A, Passante L, Gorski JA, Jones KR, Ledent C, Vanderhaeghen P: Ephrin signaling controls brain size by regulation apoptosis of neural progenitors. Nature. 2005, 435: 1244-1250. 10.1038\/nature03651.","journal-title":"Nature"},{"key":"1017_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM199101033240101","volume":"324","author":"N Weidner","year":"1991","unstructured":"Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 1991, 324: 1-8.","journal-title":"N Engl J Med"},{"key":"1017_CR33","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1158\/1541-7786.MCR-05-0056","volume":"3","author":"J Wykosky","year":"2005","unstructured":"Wykosky J, Gibo DM, Stanton C, Debinski W: EphA2 as a novel molecular marker and target in glioblastoma multiforme. Mol Cancer Res. 2005, 3: 541-551. 10.1158\/1541-7786.MCR-05-0056.","journal-title":"Mol Cancer Res"},{"key":"1017_CR34","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/(SICI)1097-0045(19991201)41:4<275::AID-PROS8>3.0.CO;2-T","volume":"41","author":"J Walker-Daniels","year":"1999","unstructured":"Walker-Daniels J, Coffman K, Azimi M, Rhim JS, Bostwick DG, Snyder P, Kerns BJ, Waters DJ, Kinch MS: Overexpression of the EphA2 tyrosine kinase in prostate cancer. Prostate. 1999, 41: 275-280. 10.1002\/(SICI)1097-0045(19991201)41:4<275::AID-PROS8>3.0.CO;2-T.","journal-title":"Prostate"},{"key":"1017_CR35","first-page":"613","volume":"9","author":"MS Kinch","year":"2003","unstructured":"Kinch MS, Moore MB, Harpole DH: Predictive Value of the EphA2 Receptor Tyrosine Kinase in lung cancer recurrence and survival. Clin Cancer Res. 2003, 9: 613-618.","journal-title":"Clin Cancer Res"},{"key":"1017_CR36","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/ijc.10860","volume":"103","author":"T Miyazaki","year":"2003","unstructured":"Miyazaki T, Kato H, Fukuchi M, Nakajima M, Kuwano H: EphA2 overexpression correlates with poor prognosis in esophogeal squamous cell carcinoma. Int J Cancer. 2003, 103: 657-663. 10.1002\/ijc.10860.","journal-title":"Int J Cancer"},{"key":"1017_CR37","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/(SICI)1097-0215(19991022)84:5<494::AID-IJC8>3.0.CO;2-O","volume":"84","author":"DJ Easty","year":"1999","unstructured":"Easty DJ, Hill SP, Hsu MY, Fallowfield ME, Florenes VA, Herlyn M, Bennett DC: Up-regulation of ephrin-A1 during melanoma progression. Int J Cancer. 1999, 84: 494-501. 10.1002\/(SICI)1097-0215(19991022)84:5<494::AID-IJC8>3.0.CO;2-O.","journal-title":"Int J Cancer"},{"key":"1017_CR38","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.1158\/1078-0432.CCR-03-0589","volume":"10","author":"PH Thaker","year":"2004","unstructured":"Thaker PH, Deavers M, Celestino J, Thornton A, Fletcher MS, Landen CN, Kinch MS, Kiener PA, Sood AK: EphA2 expression is associated with aggressive features in ovarian carcinoma. Clin Cancer Res. 2004, 10: 5145-5150. 10.1158\/1078-0432.CCR-03-0589.","journal-title":"Clin Cancer Res"},{"key":"1017_CR39","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ygyno.2004.05.019","volume":"94","author":"D Wu","year":"2004","unstructured":"Wu D, Suo Z, Kristensen GB, Li S, Troen G, Holm R, Nesland JM: Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma. Gynecol Oncol. 2004, 94: 312-319. 10.1016\/j.ygyno.2004.05.019.","journal-title":"Gynecol Oncol"},{"key":"1017_CR40","first-page":"2301","volume":"61","author":"DP Zelinski","year":"2001","unstructured":"Zelinski DP, Zantek ND, Stewart JC, Irizarry AR, Kinch MS: EphA2 overexpression causes tumorigenesis of mammary epithelial cells. Cancer Res. 2001, 61: 2301-2306.","journal-title":"Cancer Res"},{"key":"1017_CR41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1349-7006.2005.00007.x","volume":"96","author":"R Nakamura","year":"2005","unstructured":"Nakamura R, Kataoka H, Sato N, Kanamori M, Ihara M, Igarashi H, Ravshanov S, Wang YJ, Li ZY, Shimamura T, Kobayashi T, Konno H, Shinmura K, Tanaka M, Sugimura H: EPHA2\/EFNA1 expression in human gastric cancer. Cancer Sci. 2005, 96: 42-47.","journal-title":"Cancer Sci"},{"key":"1017_CR42","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1349-7006.2004.tb03194.x","volume":"95","author":"H Kataoka","year":"2004","unstructured":"Kataoka H, Igarashi H, Kanamori M, Ihara M, Wang JD, Wang YJ, Li ZY, Shimamura T, Kobayashi T, Maruyama K, Nakamura T, Arai H, Kajimura M, Hanai H, Tanaka M, Suqimura H: Correlation of EphA2 overexpression with high microvessel count in human primary colorectal cancer. Cancer Sci. 2004, 95: 136-141. 10.1111\/j.1349-7006.2004.tb03194.x.","journal-title":"Cancer Sci"},{"key":"1017_CR43","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1373\/clinchem.2003.026849","volume":"50","author":"C Hafner","year":"2004","unstructured":"Hafner C, Schmitz G, Meyer S, Bataille F, Hau P, Langmann T, Dietmaier W, Landthaler M, Vogt T: Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers. Clin Chem. 2004, 50: 490-499. 10.1373\/clinchem.2003.026849.","journal-title":"Clin Chem"},{"key":"1017_CR44","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cytogfr.2004.09.002","volume":"15","author":"H Surawska","year":"2004","unstructured":"Surawska H, Ma PC, Salgia R: The role of ephrins and Eph receptors in cancer. Cytokine Growth Factor Rev. 2004, 15: 419-433. 10.1016\/j.cytogfr.2004.09.002.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1017_CR45","doi-asserted-by":"publisher","first-page":"14442","DOI":"10.1073\/pnas.0703211104","volume":"104","author":"H Nakanishi","year":"2007","unstructured":"Nakanishi H, Nakamura T, Canaani E, Croce CM: ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias. Proc Natl Acad Sci USA. 2007, 104: 14442-14447. 10.1073\/pnas.0703211104.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1017_CR46","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.1038\/sj.onc.1208720","volume":"24","author":"JD Wang","year":"2005","unstructured":"Wang JD, Kataoka H, Suzuki M, Sato N, Nakamura R, Tao H, Maruyama K, Isogaki J, Kanaoka S, Ihara M, Tanaka M, Kanamori M, Nakamura T, Shinmura K, Sugimura H: Downregulation of EphA7 by hypermethylation in colorectal cancer. Oncogene. 2005, 24: 5637-5647. 10.1038\/sj.onc.1208720.","journal-title":"Oncogene"},{"key":"1017_CR47","unstructured":"Mitelman F, Johansson B, Mertens F: Mitelman Database of Chromosome Aberrations in Cancer. [http:\/\/cgap.nci.nih.gov\/Chromosomes\/Mitelman]"},{"key":"1017_CR48","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/ncb1438","volume":"8","author":"NK Noren","year":"2006","unstructured":"Noren NK, Foos G, Hauser CA, Pasquale EB: The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway. Nat Cell Biol. 2006, 8: 815-825. 10.1038\/ncb1438.","journal-title":"Nat Cell Biol"},{"key":"1017_CR49","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1158\/1078-0432.CCR-04-2109","volume":"11","author":"G Xia","year":"2005","unstructured":"Xia G, Kumar SR, Masood R, Koss M, Templeman C, Quinn D, Zhu S, Reddy R, Krasnoperov V, Gill PS: Up-regulation of EphB4 in mesothelioma and its biological significance. Clin Cancer Res. 2005, 11: 4305-4315. 10.1158\/1078-0432.CCR-04-2109.","journal-title":"Clin Cancer Res"},{"key":"1017_CR50","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.7973638","volume":"266","author":"S Davis","year":"1994","unstructured":"Davis S, Gale NW, Aldrich TH, Maisonpierre PC, Lhotak V, Pawson T, Goldfarb M, Yancopoulos GD: Ligands for EPH-related receptors that require membrane attachment or clustering for activity. Science. 1994, 266: 816-819. 10.1126\/science.7973638.","journal-title":"Science"},{"key":"1017_CR51","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1038\/sj.onc.1210211","volume":"26","author":"DW Dawson","year":"2007","unstructured":"Dawson DW, Hong JS, Shen RR, French SW, Troke JJ, Wu YZ, Chen SS, Gui D, Regelson M, Marahrens Y, Morse HC, Said J, Plass C, Teitell MA: Global DNA methylation profiling reveals silencing of a secreted form of EphA7 in mouse and human germinal center B-cell lymphomas. Oncogene. 2007, 26: 4243-4252. 10.1038\/sj.onc.1210211.","journal-title":"Oncogene"},{"key":"1017_CR52","doi-asserted-by":"publisher","first-page":"7011","DOI":"10.1038\/sj.onc.1205679","volume":"21","author":"DM Brantley","year":"2002","unstructured":"Brantley DM, Cheng N, Thompson EJ, Lin Q, Brekken RA, Thorpe PE, Muraoka RS, Cerretti DP, Pozzi A, Jackson D, Lin C, Chen J: Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Oncogene. 2002, 21: 7011-7026. 10.1038\/sj.onc.1205679.","journal-title":"Oncogene"},{"issue":"9","key":"1017_CR53","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1101\/gad.13.9.1055","volume":"13","author":"NW Gale","year":"1999","unstructured":"Gale NW, Yancopoulos G: Growth factors acting via endothelial cell specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes. 1999, 13 (9): 1055-1066. 10.1101\/gad.13.9.1055.","journal-title":"Genes"},{"key":"1017_CR54","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/35025215","volume":"407","author":"GD Yancopoulos","year":"2000","unstructured":"Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J: Vascular-specific growth factors and blood vessel formation. Nature. 2000, 407: 242-248. 10.1038\/35025215.","journal-title":"Nature"},{"key":"1017_CR55","doi-asserted-by":"publisher","first-page":"6043","DOI":"10.1038\/sj.onc.1204004","volume":"19","author":"K Ogawa","year":"2000","unstructured":"Ogawa K, Pasqualini R, Lindberg RA, Kain R, Freeman Al, Pasquale EB: The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization. Oncogene. 2000, 19: 6043-6052. 10.1038\/sj.onc.1204004.","journal-title":"Oncogene"},{"key":"1017_CR56","doi-asserted-by":"publisher","first-page":"5552","DOI":"10.1200\/JCO.2006.08.2073","volume":"24","author":"AP Mitra","year":"2006","unstructured":"Mitra AP, Datar RH, Cote RJ: Molecular Pathways in Invasive Bladder Cancer: New Insights Into Mechanisms, Progression, and Target Identification. J Clin Oncol. 2006, 24: 5552-5564. 10.1200\/JCO.2006.08.2073.","journal-title":"J Clin Oncol"},{"key":"1017_CR57","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/002215540305100203","volume":"51","author":"CF Chantrain","year":"2003","unstructured":"Chantrain CF, DeClerck YA, Groshen S, McNamara G: Computerized quantification of tissue vascularization using high-resolution slide scanning of whole tumor sections. J Histochem Cytochem. 2003, 51: 151-158.","journal-title":"J Histochem Cytochem"},{"key":"1017_CR58","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1158\/0008-5472.CAN-03-1957","volume":"64","author":"B Uzzan","year":"2004","unstructured":"Uzzan B, Nicolas P, Cucherat M, Perret GY: Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res. 2004, 64: 2941-2955. 10.1158\/0008-5472.CAN-03-1957.","journal-title":"Cancer Res"},{"key":"1017_CR59","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/cncr.21973","volume":"107","author":"M Preusser","year":"2006","unstructured":"Preusser M, Heinzl H, Gelpi E, Schonegger K, Haberler C, Birner P, Marosi C, Hegi M, Gorlia T, Hainfellner JA, European Organization for Research and Treatment of Cancer Brain Tumor Group: Histopathologic assessment of hot-spot microvessel density and vascular patterns in glioblastoma: Poor observer agreement limits clinical utility as prognostic factors: a translational research project of the European Organization for Research and Treatment of Cancer Brain Tumor Group. Cancer. 2006, 107: 162-170. 10.1002\/cncr.21973.","journal-title":"Cancer"},{"key":"1017_CR60","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1046\/j.1365-2990.2002.00367.x","volume":"28","author":"P Korkolopoulou","year":"2002","unstructured":"Korkolopoulou P, Patsouris E, Kavantzas N, Konstantinidou AE, Christodoulou P, Thomas-Tsagli E, Pananikolaou A, Eftychiadis C, Pavlopoulos PM, Angelidakis D, Rologis D, Davaris P: Prognostic implications of microvessel morphometry in diffuse astrocytic neoplasms. Neuropathol Appl Neurobiol. 2002, 28: 57-66. 10.1046\/j.1365-2990.2002.00367.x.","journal-title":"Neuropathol Appl Neurobiol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-79.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-8-79\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-79","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-79.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T10:30:07Z","timestamp":1630492207000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-8-79"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,25]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["1017"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-8-79","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,25]]},"assertion":[{"value":"8 August 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"79"}}